Blaustein J D, Turcotte J C
Psychology Department, University of Massachusetts, Amherst 01003.
J Neurobiol. 1990 Jul;21(5):675-85. doi: 10.1002/neu.480210502.
Progesterone injection in estradiol-primed, ovariectomized guinea pigs results in down-regulation of hypothalamic progestin receptors determined by in vitro binding assays. In order to determine if progesterone also decreases immunostaining of progestin receptors and if progestin receptors are down-regulated preferentially in particular neuroanatomical areas, ovariectomized guinea pigs were injected with doses of estradiol benzoate (10 micrograms at 42 h before progesterone injection) and progesterone (500 micrograms at 4, 12, or 24 h before perfusion) that reliably induce the expression of lordosis and subsequent behavioral refractoriness to progesterone. Progestin receptor-immunoreactive cells were counted in sections from discrete parts of the preoptic area and hypothalamus. As expected, estradiol dramatically increased cell nuclear, and, to a lesser extent, cytoplasmic, immunostaining in defined regions of the preoptic area and hypothalamus. By 12 h after progesterone injection, the number of progestin receptor-immunoreactive cells had decreased in some areas, but not others. The rostral and caudal aspects of the ventrolateral hypothalamus were particularly responsive showing a substantial decrease in progestin receptor-immunoreactivity by 12 h after injection. No decreases in the progestin receptor-immunoreactive cell number were observed in any of the preoptic regions examined, although obvious decreases in immunostaining intensity were seen. The results of these immunocytochemical experiments extend earlier findings from in vitro progestin binding experiments and demonstrate that as with progestin binding, progestin receptor-immunoreactivity decreases when progesterone is injected in a behavioral desensitization procedure. Furthermore, they point to the ventrolateral hypothalamus as one site in which the down-regulation of progestin receptors may be particularly responsive to progesterone.
在经雌二醇预处理的去卵巢豚鼠中注射孕酮,通过体外结合试验测定发现,下丘脑孕激素受体出现下调。为了确定孕酮是否也会降低孕激素受体的免疫染色,以及孕激素受体是否在特定神经解剖区域优先下调,给去卵巢豚鼠注射苯甲酸雌二醇(在注射孕酮前42小时注射10微克)和孕酮(在灌注前4、12或24小时注射500微克),这些剂量能可靠地诱导脊柱前凸的表达以及随后对孕酮的行为不应性。对来自视前区和下丘脑不同部位的切片中的孕激素受体免疫反应性细胞进行计数。正如预期的那样,雌二醇显著增加了视前区和下丘脑特定区域的细胞核免疫染色,在较小程度上也增加了细胞质免疫染色。注射孕酮后12小时,某些区域的孕激素受体免疫反应性细胞数量减少,但其他区域没有。下丘脑腹外侧的头端和尾端部分反应特别明显,注射后12小时孕激素受体免疫反应性显著降低。在所检查的任何视前区均未观察到孕激素受体免疫反应性细胞数量减少,尽管免疫染色强度明显降低。这些免疫细胞化学实验的结果扩展了早期体外孕激素结合实验的发现,并证明与孕激素结合一样,在行为脱敏程序中注射孕酮时,孕激素受体免疫反应性会降低。此外,它们指出下丘脑腹外侧是孕激素受体下调可能对孕酮特别敏感的一个部位。